Noveris Health Sciences Inc. (MYCOF)
Develops medications to treat nicotine addiction and PTSD using empathogenic compounds
$0.80+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+166.7%
The outlook
MYCOF is trading near the lower end of its 52-week range, positioned about 38% of the way from low to high. The stock shows mixed momentum relative to its moving averages, with analyst coverage appearing thin. The overall sentiment leans neutral with a score of 54/100.
What’s behind the score
Price trendMixed vs its moving averages
52-week range38% of the way from its 52-week low to high
Market cap
$46.8M
52-wk high
$2.04
52-wk low
$0.03
50-day avg
$1.47
200-day avg
$0.70
Trailing P/E
0.4